Mark Gray
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Bioengineering top 10%
- Analytical Chemistry and Sensors
Papers in
- Oncology 13
- Cancer Cells and Metastasis 4
- HER2/EGFR in Cancer Research 4
- Co-authors
- James Meehan (24 shared papers)David J. Argyle (17 shared papers)Simon P. Langdon (8 shared papers)Carol Ward (8 shared papers)Ian Kunkler (9 shared papers)Arran Turnbull (14 shared papers)Carlos Martínez-Pérez (14 shared papers)Charlene Kay (12 shared papers)
- Journals
- Journal of Personalized Medicine (6 papers)Frontiers in Oncology (4 papers)Frontiers in Veterinary Science (3 papers)Veterinary Immunology and Immunopathology (2 papers)Cancer Research (2 papers)
- Partner nations
- United KingdomUnited StatesMalaysia
In The Last Decade
Mark Gray
36 papers receiving 935 citations
Peers
Comparison fields: 5 of 121
- Cancer Research 185
- Bioengineering 41
- Oncology 169
- Microbiology 5
- Small Animals 44
Countries citing papers authored by Mark Gray
This map shows the geographic impact of Mark Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Gray more than expected).
Fields of papers citing papers by Mark Gray
This network shows the impact of papers produced by Mark Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Gray. The network helps show where Mark Gray may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Gray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 134 | |
| 2 | 2020 | 117 | |
| 3 | 2020 | 87 | |
| 4 | 2019 | 75 | |
| 5 | 2018 | 56 | |
| 6 | 2017 | 51 | |
| 7 | 2020 | 47 | |
| 8 | 2021 | 38 | |
| 9 | 2019 | 32 | |
| 10 | 2021 | 30 | |
| 11 | 2015 | 29 | |
| 12 | 2021 | 22 | |
| 13 | 2018 | 22 | |
| 14 | 2021 | 20 | |
| 15 | 1987 | 20 | |
| 16 | 2021 | 17 | |
| 17 | 2019 | 15 | |
| 18 | 1973 | 13 | |
| 19 | 2021 | 12 | |
| 20 | 2021 | 12 |
About Mark Gray
Mark Gray is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 40 papers that have together received 945 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), HER2/EGFR in Cancer Research (4 papers), Veterinary Oncology Research (3 papers), Infectious Diseases and Mycology (3 papers), Analytical Chemistry and Sensors (3 papers), T-cell and B-cell Immunology (3 papers), Advanced Breast Cancer Therapies (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Cancer Research (185 citations), Bioengineering (41 citations), Oncology (169 citations), Microbiology (5 citations) and Small Animals (44 citations). Mark Gray has collaborated with scholars based in United Kingdom, United States and Malaysia. Frequent co-authors include James Meehan, David J. Argyle, Simon P. Langdon, Carol Ward, Ian Kunkler, Arran Turnbull, Carlos Martínez-Pérez, Charlene Kay, Lisa Y. Pang and Alan F. Murray. Their work appears in journals such as Journal of Personalized Medicine, Frontiers in Oncology, Frontiers in Veterinary Science, Veterinary Immunology and Immunopathology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.